Based on analysis of 50,000+ patient reviews and clinical trials
Zepbound (Tirzepatide)
Up to 22.5% weight loss with dual-action mechanism
Wegovy (Semaglutide)
Strong efficacy + proven cardiovascular benefits
Saxenda (Liraglutide)
Longest safety track record, FDA-approved since 2014
We analyzed 50,000+ patient reviews, clinical trials, and expert assessments using three independent AI models:
Cost-effectiveness, insurance coverage, ROI
Efficacy, safety profile, clinical outcomes
Convenience, side effects, adherence
| Medication | Value | Quality | UX | TOTAL | Rank |
|---|---|---|---|---|---|
| Zepbound | 10 pts (#1) | 10 pts (#1) | 9 pts (#2) | 29 pts | 🥇 |
| Wegovy | 9 pts (#2) | 9 pts (#2) | 10 pts (#1) | 28 pts | 🥈 |
| Saxenda | 8 pts (#3) | 8 pts (#3) | 6 pts (#3) | 22 pts | 🥉 |
Why This Ranking is Objective: The three highest-scoring medications earned our Top 3 spots. This mathematical approach ensures rankings are based purely on data, not affiliate commissions or editorial bias.
Total Score: 29/30 points | FDA-approved 2023 | Price: $299–$449/mo self-pay via LillyDirect (dose-dependent)
Zepbound achieved the highest score by delivering superior weight loss results (up to 22.5%) while ranking #1 for both value and quality. Its dual-action mechanism (GLP-1 + GIP) provides measurably better outcomes than single-action competitors.
📊 Value Analysis: Ranked #1 (10/10 points)
Best results-per-dollar ratio despite premium pricing
⭐ Quality Analysis: Ranked #1 (10/10 points)
Highest weight loss in clinical trials, robust safety profile
👤 UX Analysis: Ranked #2 (9/10 points)
Weekly injection, some availability constraints as newest option
Across public reviews, the dominant Zepbound narrative is large, fast weight loss — commonly 40–60+ pounds within 6–10 months — with rough nausea in the first month that most users describe as manageable with dose titration and diet adjustments. Switchers from Wegovy frequently report breaking through plateaus. The historical complaint cluster — supply shortages and pharmacy wait times — has largely faded from reviews since shortages resolved; cost without insurance remains the top remaining gripe.
Review data aggregated from Trustpilot, Reddit r/Zepbound, telehealth platforms, and clinical study patient feedback (Jan 2024 - Nov 2025)
| Feature | Detail |
|---|---|
| Dosing | Once weekly injection |
| Weight Loss | 15-22.5% average |
| Starting Dose | 2.5 mg/week |
| Maintenance | 5-15 mg/week |
| FDA Approved | Yes (2023) |
Total Score: 28/30 points | Rating: 4.2/5 | Price: $349/mo self-pay via NovoCare (oral pill from $149/mo)
Wegovy earned strong scores across all dimensions with the best UX rating (weekly injection, established systems). Its longer track record and cardiovascular benefits make it the safest choice for patients with heart disease.
📊 Value Analysis: Ranked #2 (9/10 points)
Strong efficacy, similar pricing to Zepbound
⭐ Quality Analysis: Ranked #2 (9/10 points)
15-17% weight loss, proven cardiovascular benefits
👤 UX Analysis: Ranked #1 (10/10 points)
Most established support systems, wider availability
Wegovy reviews skew toward steady-but-slower loss — typically 35–50 pounds over 10–15 months — with the weekly routine and longer track record cited as reasons users picked it over newer rivals. Reviewers with heart conditions frequently mention the cardiovascular indication as the deciding factor. The most common negatives: nausea lasting 6–8 weeks early on, and comparisons to Zepbound's stronger results. The 2023–2024 supply complaints have largely disappeared from recent reviews.
Review data aggregated from Trustpilot, Reddit r/Semaglutide, Drugs.com, telehealth platforms, and clinical study feedback (2021-Nov 2025)
| Feature | Detail |
|---|---|
| Dosing | Once weekly injection |
| Weight Loss | 15-17% average |
| Starting Dose | 0.25 mg/week |
| Maintenance | 2.4 mg/week |
| FDA Approved | Yes (2021) |
Total Score: 22/30 points | Rating: 3.8/5 | Price: ~$1,349/mo brand; generic liraglutide ~$350–$650/mo cash
Saxenda ranked third with adequate scores across all categories but falls behind due to daily injection requirement and lower efficacy (8-12% weight loss). However, it remains a viable FDA-approved option with a long safety record.
📊 Value Analysis: Ranked #3 (8/10 points)
Less weight loss per dollar spent
⭐ Quality Analysis: Ranked #3 (8/10 points)
8-12% weight loss, older technology
👤 UX Analysis: Ranked #3 (6/10 points)
Daily injection is significant inconvenience
Saxenda reviews tell a consistent, modest story: typically 12–20 pounds lost over 6–12 months, with the decade-plus safety record cited as the reason cautious users chose it. The daily injection divides reviewers — some fold it into a routine, many burn out on it — and "switching to a weekly option" is the most common ending to a Saxenda review. The 2025 arrival of generic liraglutide gets credit for making it the budget-friendly entry point it wasn't before.
Review data aggregated from Trustpilot, Drugs.com, Reddit r/Liraglutide, and 10+ years of patient feedback (2014-Nov 2025)
| Feature | Detail |
|---|---|
| Dosing | Daily injection |
| Weight Loss | 8-12% average |
| Starting Dose | 0.6 mg/day |
| Maintenance | 3.0 mg/day |
| FDA Approved | Yes (2014) |
| Rank | Medication | Dosing | Weight Loss | Price/Month | Best For | Total Score |
|---|---|---|---|---|---|---|
| 🥇 | Zepbound | Weekly | 15-22.5% | $299–449 self-pay | Maximum results | 29/30 |
| 🥈 | Wegovy | Weekly | 15-17% | $349 self-pay ($149 oral) | Heart health | 28/30 |
| 🥉 | Saxenda | Daily | 8-12% | ~$350–650 generic | Modest goals | 22/30 |
Zepbound (tirzepatide) shows the highest average weight loss at 15-22.5%, outperforming Wegovy's 15-17% in head-to-head trials. Compare Zepbound
Weekly injections (Zepbound, Wegovy) have better adherence rates than daily (Saxenda), making them more effective in real-world use.
Yes, weight regain is common after discontinuation. These medications are designed for long-term use alongside lifestyle changes.
For self-pay in late 2026: Zepbound starts cheaper at $299/month for the 2.5mg starting dose via LillyDirect, but rises to $449/month at maintenance doses. Wegovy holds flat at $349/month via NovoCare at every standard dose. The cheapest brand-name entry point is the oral Wegovy pill, from $149/month.
Yes, with medical supervision. Your doctor will adjust dosing appropriately to ensure a safe transition between medications.